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defining clinical decision support objectives
applicable to medical specialties
Justin W Timbie1*, Cheryl L Damberg2, Eric C Schneider3 and Douglas S Bell4Abstract
Background: The U.S. Centers for Medicare and Medicaid Services established the Electronic Health Record (EHR)
Incentive Program in 2009 to stimulate the adoption of EHRs. One component of the program requires eligible
providers to implement clinical decision support (CDS) interventions that can improve performance on one or more
quality measures pre-selected for each specialty. Because the unique decision-making challenges and existing HIT
capabilities vary widely across specialties, the development of meaningful objectives for CDS within such programs
must be supported by deliberative analysis.
Design: We developed a conceptual framework and protocol that combines evidence review with expert opinion
to elicit clinically meaningful objectives for CDS directly from specialists. The framework links objectives for CDS to
specialty-specific performance gaps while ensuring that a workable set of CDS opportunities are available to
providers to address each performance gap. Performance gaps may include those with well-established quality
measures but also priorities identified by specialists based on their clinical experience. Moreover, objectives are not
constrained to performance gaps with existing CDS technologies, but rather may include those for which CDS tools
might reasonably be expected to be developed in the near term, for example, by the beginning of Stage 3 of the
EHR Incentive program. The protocol uses a modified Delphi expert panel process to elicit and prioritize CDS
meaningful use objectives. Experts first rate the importance of performance gaps, beginning with a candidate list
generated through an environmental scan and supplemented through nominations by panelists. For the highest
priority performance gaps, panelists then rate the extent to which existing or future CDS interventions,
characterized jointly as “CDS opportunities,” might impact each performance gap and the extent to which each
CDS opportunity is compatible with specialists’ clinical workflows. The protocol was tested by expert panels
representing four clinical specialties: oncology, orthopedic surgery, interventional cardiology, and pediatrics.Introduction
Clinical decision support (CDS) is the process of provid-
ing persons involved in patient care with intelligently fil-
tered and organized information, at appropriate times,
to enable decisions that optimize health care and health
outcomes.a The guidance and prompts that CDS can
provide constitute one of the primary mechanisms by
which electronic health records (EHR) can transform the
quality and efficiency of health care delivery [1]. Various
studies have demonstrated that CDS can influence clin-
ical practice by helping clinicians to improve diagnosis* Correspondence: jtimbie@rand.org
1RAND Corporation, 1200 South Hayes Street, Arlington, VA 22202, USA
Full list of author information is available at the end of the article
© 2012 Timbie et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or[2-8], improve quality and patient safety [9-17], adhere
to guidelines for prevention and treatment [18-24], and
avoid medication errors [25-30].
However, the actual use of CDS within EHRs has been
uneven [31, 32]. A systematic review of CDS related to
medication prescribing cited poor integration of CDS
into clinical workflows and limited relevance and timeli-
ness of clinical messaging as two key implementation
barriers [33]. The review also found that CDS interven-
tions that were endorsed by colleagues, facilitated
doctor-patient interactions, and minimized perceived
threats to professional autonomy, were more readily
adopted. Other experts have noted that the effectiveness
of CDS interventions could be significantly enhancedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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effective summaries of vast quantities of information
relevant to specific decision making contexts, and by
accounting for patients’ comorbidities in clinical recom-
mendations [34]. Many such barriers must be addressed
before CDS can truly transform clinical care.
To that end, the Health Information Technology for
Economic and Clinical Health Act (HITECH), authorized
the Centers for Medicare and Medicaid Services (CMS) to
provide incentive payments to eligible providers who suc-
cessfully demonstrate “meaningful use” of EHRs--
including the use of CDS [35]. The initial rules proposed
for the EHR Incentive Program included a requirement
that providers implement 5 CDS artifacts, each targeted to
address one of the specific clinical quality measures that
had been designated as options for quality reporting. The
final rule required only that providers attest to having
implemented one “appropriate” clinical decision support
rule that is relevant to the provider’s specialty. The change
in approach between the proposed and final rule was re-
sponsive to commenters’ concerns that fewer than 5 qual-
ity measures would likely be reported by most eligible
professionals, and that explicitly linking CDS requirements
to clinical quality measures would “put constraints on pro-
viders and eliminate many types of CDS that could be
beneficial.” [36] Instead, selection of the CDS rule to im-
plement was left to providers, who could take into account
their workflow, patient population, and quality improve-
ment efforts. This change was recognized as an interim
step taken in the absence of consensus standards for clin-
ically specific CDS requirements. The Stage 2 proposed
rule recently reinstated the 5 artifact requirement [37].
The clinical knowledge that should underlie CDS
recommendations and the technology available to deliver
the knowledge are both rapidly evolving, making it chal-
lenging to specify clinically precise meaningful use
objectives for CDS. Moreover, performance gaps differ
widely across specialties and clinical conditions, making
the priorities for the optimal use of CDS potentially dis-
tinct within each specialty domain. No framework exists
to systematically assess potential CDS objectives to en-
sure that 1) they address the most critical gaps in care,
and 2) they are clinically meaningful to the broad range
of specialties participating in the Medicare and Medicaid
EHR Incentive Programs.
To begin laying the groundwork for clinically specific
standards for high-priority CDS, the Office of the Na-
tional Coordinator for Health IT (ONC) sought the de-
velopment of a methodology that would allow experts to
define consensus objectives for CDS that would be clin-
ically meaningful within their specialty and that might
later be transformed into specific meaningful use objec-
tives for CDS for future stages of the EHR Incentive Pro-
gram. This paper describes the development of aframework and protocol to elicit high-priority “CDS tar-
gets” from panels of specialists, comprising high priority
clinical performance gaps within their specialty that are
amenable to CDS. We begin by presenting our concep-
tual framework for specifying high-priority CDS targets.
Next, we describe our methodology for identifying can-
didate clinical performance gaps and CDS opportunities,
and the selection, design, and composition of panels for
pilot testing the protocol. We then summarize the
results of the pilot and the strengths and limitations of
the protocol. A detailed report of the study’s method-
ology and results is available at: http://www.rand.org/
pubs/technical_reports/TR1129.html.
Conceptual framework for specifying high-priority
CDS targets
Our approach to defining potential CDS objectives
began with a recognition that EHRs could potentially
use many kinds of CDS features to target a specific clin-
ical performance gap. For example, the overuse of anti-
biotics in upper respiratory infections might be targeted
by an alert if an antibiotic is prescribed when documen-
tation does not warrant it or by a smart form that guides
documentation and therapy selection. In most cases, not
only would there be insufficient evidence to determine
which CDS intervention is most effective to codify as a
specific CDS objective, but furthermore, CDS objectives
should be flexible enough to accommodate the rapid
pace of innovation in these technologies. On the other
hand, meaningful use objectives need to include specific
EHR features that can be assessed as present or absent
in a given EHR and for which clinician usage can be
measured. Given these constraints, we sought to specify
CDS “targets,” rather than discrete CDS interventions,
that might serve as the basis for future objectives.
We conceptualized a CDS target as a “clinical per-
formance gap” that could be addressed by CDS. Further,
we conceptualized high priority CDS targets as the
most critical clinical performance gaps that have one or
more CDS opportunities that can be implemented to ad-
dress the performance gap that were both effective and
compatible with clinical workflow (Figure 1). In the fol-
lowing sections we define clinical performance gaps and
CDS opportunities and provide examples of each.
Clinical Performance Gaps are clinical areas in which
actual practice does not conform to optimal achievable
practice. Performance gaps might include:
 Failures to deliver care when indicated;
 Inappropriate use of diagnostic tests or procedures;
 Preventable adverse events;
 Disparities or unwanted variations in care delivery; or
 Deficiencies in patients’ experience of care (e.g.,
engagement in decision-making)
Clinical Performance Gaps
Quality Measures
High Priority CDS Targets:
Performance gaps having
effective and feasible CDS
Opportunities
Figure 1 Conceptual framework for defining high priority CDS targets.
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ciated with a formal quality measure. Figure 1 illustrates
the relationship between quality measures and perform-
ance gaps. Although quality measures should always
emerge from some recognition of a performance gap,
they require many other considerations, including the
strength of evidence supporting the desired action, the
availability of data to measure each indicator, and the de-
gree to which providers can be held accountable for their
performance on the measure. By contrast, the evidence
underlying clinical performance gaps may include clinical
epidemiology or anecdotal observation in addition to em-
pirical research. Many performance gaps in specialty care
do not have associated quality measures because measure
development and validation can be a laborious and
lengthy process. Thus, as shown in Figure 1, there are
many important performance gaps for which quality
measures do not exist but which still represent opportun-
ities for improving the quality of care.
CDS opportunities A CDS opportunity is a description
of a specific CDS intervention, including existing inter-
ventions or those that might be developed in the near
term, that could be expected to address a clinical
performance gap. CDS opportunities might include
alerts, order sets, and documentation templates, among
other types of interventions. Only a subset of CDSTable 1 Four illustrative CDS targets: clinical performance ga
Clinical Performance Gap
Many patients receiving chemotherapy are at risk of experiencing adverse
events due to errors in chemotherapy ordering. [Oncology]
Patients undergoing total hip or total knee replacement surgery may not
receive VTE prophylaxis when it is indicated. [Orthopedic surgery]
Nearly half of patients with STEMI receive no reperfusion therapy or receive
delayed reperfusion (>12 hours after onset). [Interventional cardiology]
Children with asthma are not routinely monitored for control of their
condition. [Pediatrics]
Notes: VTE = Venous Thromboembolism, STEMI = ST Segment Elevation Myocardial iopportunities might be amenable to addressing particu-
lar performance gaps (Figure 1), due to either the
effectiveness of current CDS technology or to the com-
patibility of those technologies with the unique aspects
of workflow within the specialty.
The main task of the panel was to consider the im-
portance of an initial set of performance gaps, and then
to consider the strength of the CDS opportunities for
the highest rated gaps. “High priority CDS targets” were
those performance gaps that were both rated highly im-
portant and for which the CDS opportunities to close
the gap were rated as having high potential impact and
being highly compatible with clinical workflows. Table 1
provides a sample of clinical performance gaps from
each of the four specialties and an associated CDS
opportunity.
Methodology for identifying candidate clinical
performance gaps and CDS opportunities
In preparation for each expert panel, study staff worked
with the panel chair and co-chair to identify candidate
clinical performance gaps and CDS opportunities from a
wide range of sources.
Clinical performance gaps We used three approaches
to identify candidate clinical performance gaps for
each panel. First, we scanned existing quality measureps and CDS opportunities
CDS opportunity targeting the gap
Alert at the time of ordering or infusion if chemotherapy orders differ
from accepted standards
Order set for VTE prophylaxis that recommends treatment customized
to patient’s bleeding risk and that conforms to guidelines
Alert to inform ED physician and staff of possible ACS diagnosis
triggered by abnormal biomarkers
Pathway to guide dose escalation or medication substitution
nfusion, ED= Emergency Department, ACS =Acute Coronary Syndrome.
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including the National Quality Measures Clearinghouse,
National Quality Forum, Physician Quality Reporting
System, National Committee for Quality Assurance,
American Medical Association Physician Consortium for
Performance Improvement, Hospital Inpatient Quality
Reporting Program, Premier Hospital Quality Incentive
Demonstration, and the quality measures selected for
reporting in the Stage 1 proposed rule for the Medicare
and Medicaid EHR Incentive Programs. Quality mea-
sures selected as relevant for each specialty were restated
as declarative gap statements (Table 1). Second, we con-
ducted an environmental scan to collect data, where
available, on the prevalence of each performance gap
and the clinical and economic outcomes of each gap—
including both morbidity and mortality if appropriate—
to provide panelists with a source of objective informa-
tion about the relative importance of each gap prior to
the ratings. Finally, we reviewed the preliminary list of
performance gaps with the panel co-chairs, who recom-
mended additions and/or revisions to the list. During
the panel’s first meeting, we asked panelists to nominate
additional performance gaps, which were included in the
rating process. Throughout, we sought to represent gaps
from each of the six priority domains of the National
Priorities Partnership [38] — patient and family engage-
ment, population health, safety, care coordination, pallia-
tive and end-of-life care, and elimination of overuse.
CDS opportunities We then identified CDS opportun-
ities for each of the clinical performance gaps using an
approach depicted in Figure 2. First, for each perform-
ance gap, we identified one or more clinical actions that
physicians and other health care professionals could take
to address the clinical performance gap based on teamFigure 2 Approach for specifying CDS opportunities for clinical perfomembers’ clinical experience. Second, we considered
how specific CDS interventions could support providers
in taking those clinical actions. These choices were influ-
enced by two other factors: 1) the type of information
that would be needed by (and available to) the CDS tool
to be able to support the clinical action, and 2) consider-
ation of the clinical workflow into which the tool might
be inserted. For each specialty area, we conducted a scan
of the published literature for specific CDS interventions
that had been used within the specialty domain, and
abstracted data on their effectiveness and their impact
on workflow. We were unable to collect data on CDS
tools in development or those for which evaluations
were not published in the peer-reviewed literature.
To supplement the tools described in the literature, we
worked with the panel co-chairs to identify additional
CDS interventions. We sought to identify both existing
tools and CDS concepts—assuming that there would be
adequate lead time to allow vendors to develop these
tools before later stages of meaningful use objectives
were released. Although we did not provide panelists
with an opportunity to add candidate CDS opportunities
because of time constraints, such an approach would be
desirable.
We also sought to identify CDS opportunities that
covered a broad range of CDS categories. We used a tax-
onomy developed by Osheroff and colleagues [39] that
included six categories of CDS interventions (Table 2).
In Table 3, we provide examples of the workflow ele-
ments that guided the development of CDS opportun-
ities. No comprehensive workflow framework was
available to draw on to select optimal insertion points in
workflows. Moreover, different clinicians or practice
organizations may insert different forms of CDS into dif-
ferent workflows, and so a one-size-fits all approach mayrmance gaps.
Table 2 CDS intervention categories with examples
Category Examples
Documentation forms and templates Clinician encounter documentation forms; patient self-assessment forms;
“smart forms;” data flow sheets
Relevant data presentation Relevant data for ordering, administration, or documentation;
retrospective/aggregate reporting or filtering; choice lists; practice status display
Order/prescription creation facilitators Order sets; tools for complex ordering
Protocol and pathway support Stepwise processing of multistep protocol or guideline; support for managing
clinical problems over long periods and many encounters
Reference information and guidance Context-specific direct links to specific, pertinent reference information
Alerts and reminders Alerts to prevent potential/omission/commission errors or hazards; alerts
to foster best care
Note: A “smart form” is an EHR-based clinical workflow tool designed for organized data review for specific conditions, effective and efficient facilitated data
capture, documentation of a clinical visit, and integrated, dynamic, actionable decision support in a single environment [40].
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purposes of this project decomposes workflow into spe-
cific tasks, the actors or persons who take action, and
the settings in which the task might occur.
Expert panel protocol
Meeting format and rating process We used a telecon-
ference meeting format with webinar, hosting three 90-
minute teleconferences with each panel (Figure 3).
Across these three meetings the panelists completed two
modified Delphi rating processes, one focused on rating
the importance of each performance gap, and the sec-
ond focused on rating, for each important performance
gap, the compatibility of CDS with clinical workflow and
the potential impact for CDS to close the performance
gap. Each rating process began with an initial round of
ratings that the panelists conducted independently and
confidentially. Panelist ratings were then compiled for
review and discussion on a panel teleconference, and the
discussion was then followed immediately by a second
round of ratings, which the panelists were asked to
complete before leaving the call. Panelists submitted
their ratings electronically to facilitate data collection,
ensure completeness of data, and to expedite the
analysis.Table 3 Examples of workflow elements
Tasks Actors
Prescribing • Specialist
Ordering a test • Physicians’ ass
Gathering clinical data from a patient • Nurse
Interpreting a test result • Advanced pra
Generating a note or consult report • Administrative
Receiving a consult report • Visiting nurse
Communicating results to a patient • Patient, family
Discharging a patientPanelists received a summary of the first round of rat-
ings prior to attending the second and third calls to
allow them to review their ratings relative to those of
other panelists. Table 4 shows a one page example of a
report from the first round of ratings of the oncology
CDS opportunities. Panelists could see the distribution
of initial ratings by looking at the numbers above the 1
to 9 rating line, which shows counts of the number of
panelists who selected each value. For example, 2 pane-
lists assigned a rating of “6” for the compatibility of the
first CDS opportunity for addressing Gap #3 (a smart
form that captures pain intensity). Each panelist received
a different printout; the distribution of ratings was the
same on all reports, but the caret (^) below the rating
line showed the initial rating assigned by an individual
panelist.
During the second and third teleconferences, the dis-
cussion of first round gap and CDS opportunity ratings
was led by a clinician who was involved in developing
the initial list of gap statements and associated CDS op-
portunities. The discussion during the second and third
teleconferences focused on those items that, after ana-
lysis of the first round of ratings, were associated with
“indeterminate” levels of agreement based on the disper-
sion in panelists’ ratings (See Analysis of Ratings, below).
After discussion, the panelists were then asked toSettings
• Office
istant • Ambulatory clinic
• Hospital
ctice registered nurse • Emergency department
assistant • Ambulatory surgery center
• Patient web portal
, or caregiver
Figure 3 Expert panel protocol.
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(during teleconference #2) and gap-CDS opportunity
pairs both individually and as a set of opportunities for a
given gap statement (during teleconference #3).Table 4 Sample panelist rating report depicting the distributi
Oncology Gaps/CDS Opportunities
Gap #3: The presence of pain and its intensity are inadequately assessed or
quantified in cancer patients receiving chemotherapy or radiation therapy,
and pain management plans are not routinely documented.
Smart form that captures pain intensity and generates pain management
plan based on patient preference and particular history
Display cancer pain history with intensity levels and current/prior
treatments for pain
Order set for cancer pain medication that results in a comprehensive
management plan
Pathway to guide initial selection of pain medication and to guide
escalation of therapy when required
Reminders to assess and to quantify pain at appropriate
moments in workflow
Overall rating
Note: The figure displays a portion of a rating report provided to Panelist #13. The
rating scale. Each panelist’s own rating is indicated by a caret. For example, two pan
the first CDS opportunity, a smart form that captures pain intensity.Rating criteria We developed three criteria for panelists
to use to rate individual performance gaps and CDS
opportunities (Tables 5 and 6). In defining the import-
ance criterion, we looked to the National Prioritieson of panelists’ ratings and the panelist’s own rating
Compatibility Potential Impact
1 1 2 5 3 1 3 3 4 1
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
^ ^
1 2 1 1 6 1 1 2 2 3 2 2
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
^ ^
3 3 4 2 1 3 6 2
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
^ ^
2 4 3 3 1 1 4 5 1
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
^ ^
1 1 3 6 1 1 1 6 4
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
^ ^
1 1 5 4 1 1 1 3 6 1
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
^ ^
distribution of all panelists’ ratings are depicted in the row directly above the
elists (including Panelist #13) assigned a rating of 6 for the compatibility of
Table 5 Rating criteria used to elicit CDS priority
performance gap-CDS opportunities: clinical performance
gaps
Criterion 1:
Importance
• Affects a relatively large number of patients
(prevalence)
• On average, there are significant
consequences to the patient in terms
of increased risk of morbidity or mortality
• The gap may be addressed by patient
engagement and delivery of more
patient-centered care
• Poor performance leads to inefficient use of
resources/waste in health care spending
• Scientific evidence or professional
consensus exists on one or more actions
to address the performance gap
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of importance, from which we selected three: 1) popula-
tion health (i.e., prevalence, health impact on indivi-
duals), 2) patient engagement, and 3) efficiency. We also
included an additional dimension, the extent to which
evidence supports specific scientific actions to address
each performance gap. In assessing compatibility, pane-
lists were instructed to consider a range of practice
workflows into which the CDS intervention might be
inserted including their own workflows, those of ancil-
lary staff, and those that might be common in other
practice settings. This criterion was considered import-
ant because the timing with which CDS is introduced in
a workflow and its level of intrusiveness could impact
the overall utility of the tool. In assessing the potential
impact of CDS on the performance gap, panelists were
asked to imagine how CDS tools would promote actions
to address each gap. Panelists used a nine-point scale
with the following anchors: for performance gap ratings
(1 =Not at all important; 5 = Equivocal; 9 = Extremely
important)) and for CDS opportunities (1 =Not at allTable 6 Rating criteria used to elicit CDS priority
performance gap-CDS opportunities: CDS opportunities
Criterion 1: Compatibility
of CDS with workflow
• One or more of the CDS tools within
the opportunity set can be readily
introduced into a specialist’s workflow
and/or the workflow of others on the
care team
• The specialist or other members of the
care team are likely to use the CDS tools
in daily practice
Criterion 2: Potential
impact of CDS on the
performance gap
• Information deficiencies or low-reliability
systems are the main contributor to the
performance gap rather than clinical
uncertainty, insufficient scientific evidence,
or other factors
• The CDS tool can provide the majority of
the information needed to address the
clinical gapcompatible/No potential impact; 5 = Equivocal; 9 = Ex-
tremely compatible/Extremely high potential impact).Analysis of ratings
Following conventional methods for analyzing data from
a modified Delphi process [41], we computed three sets
of estimates for each performance gap and CDS oppor-
tunity. First, we calculated median ratings to measure
the central tendency for the set of panelists’ ratings. We
then estimated mean absolute deviations from the me-
dian to measure the dispersion of the ratings. Third, we
classified ratings as exhibiting agreement, disagreement,
or indeterminate levels of agreement, using nonpara-
metric decision rules that take into account the distribu-
tion of panelists’ scores. “Agreement” is achieved when
panelists’ ratings converge tightly around the median rat-
ing, while “disagreement” reflects a polarization of opin-
ion that occurs when a large number of panelists provide
ratings in both extremes of the rating scale. Because typ-
ical rules for measuring agreement are based on panels
of size 9 and our panels ranged in size from a low of 12
to a high of 17, we followed the generalized scoring
method identified in the RAND/UCLA Appropriateness
Method manual [41] for measuring disagreement and
agreement with larger panels, as shown in Table 7.
According to the RAND/UCLA Appropriateness
Method, classification of results depends only on median
ratings and the presence or absence of disagreement.
Performance gaps with median ratings in the top third
of the 9-point scale without disagreement are classified
as important, those with median ratings in the bottom
third without disagreement are classified as unimport-
ant, and those with intermediate median ratings or any
median with disagreement are equivocal (Table 8). How-
ever, we used more restrictive criteria to identify high
priority clinical performance gaps, by requiring that each
gap have both a median rating between 7 and 9 and ex-
hibit statistical agreement. Items with indeterminate
levels of agreement were not considered high priority. ATable 7 Definitions of agreement and disagreement for
different panel sizes
Agreement Disagreement
Panel
size
Number of panelists
rating outside the
3-point region containing
the median
Number of panelists
rating in each extreme
third of the scale
(1-3 and 7-9)
8-10 ≤2 ≥3
11-13 ≤3 ≥4
14-16 ≤4 ≥5
Note. Definitions of disagreement and agreement reflect the default
definitions according to the developers of the RAND/UCLA Appropriateness
Method. These are also the most widely used definitions.
Table 8 Classification of performance gaps and CDS opportunities based on median ratings and statistical agreement,
by rating criterion
Rating Criterion Rating result
Median: 1-3 AND No
Disagreement*
Median: 4-6 OR
Disagreement
Median: 7-9 AND
Indeterminate
Agreement
Agreement**
Performance gaps Importance Unimportant Equivocal Important Important – highest priority
CDS opportunities Compatibility Incompatible with
clinical practice
Equivocal Compatible with
clinical practice
Compatible with clinical
practice – highest priority
Potential impact Low potential impact Equivocal High potential
impact
High potential impact –
highest priority
*“No disagreement” implies either “agreement” or “indeterminate agreement”.
**While the RAND/UCLA Appropriateness Manual (RAM) only requires median ratings in the 7-9 range and the absence of disagreement to classify items as high
priority, we used a higher bar, by requiring that each criterion exhibit statistical agreement. Items with indeterminate levels of agreement were not considered
high priority.
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ities for the high priority gaps.
Items that were classified as “equivocal” were not dis-
cussed after the first round of ratings. After the second
round of rating the performance gaps, we moved for-
ward the 8 highest rated gaps (+/- 4 gaps) that achieved
“agreement” for having the panels consider CDS oppor-
tunities. This cut point was set to allow adequate time to
discuss the one or more CDS opportunities for each per-
formance gap in the third call, given the 90 minute
phone call constraint.
From the two sets of ratings provided by experts on
each panel, we compiled a list of high priority targets for
CDS. Performance gaps that were highly rated on im-
portance and for which the set of CDS tools or concepts
was rated as being compatible with clinical practice and
had a high potential impact on addressing the perform-
ance gap were designated high priority CDS targets.
Selection of specialty-specific vs. condition-
specific scope for expert panels
Constructing a panel first involves selecting the clinical
domain that the panel will be asked to address. Concep-
tually, the focus of CDS prioritization could be on the
breadth of problems within a single specialty or specialty
subdomain (e.g., gastroenterology, including peptic ulcer
disease, gastrointestinal malignancies, etc.) or it could
focus on a condition from the perspective of the mul-
tiple specialties that treat the condition (e.g., viral hepa-
titis, including hepatologists, primary care physicians,
infectious disease specialists, and transplant surgeons).
Specialty-specific panels might be more likely to gener-
ate CDS priorities that are considered highly relevant
within the specialty, however, this approach might
reinforce the “silo” nature of medicine by failing to in-
clude the full scope of care provided for the conditions
in question. A condition-specific approach, by contrast,
provides an opportunity to bring together perspectivesfrom a broad set of specialists to prioritize CDS that
would best improve care for the condition, regardless of
specialty. However, this approach would likely cover
fewer conditions than the specialty-specific approach
and it might have a higher risk of producing CDS prior-
ities that miss the mark for specialties that are not
strongly represented on the panel. Given these tradeoffs,
we sought to include each kind of panel in pilot testing.
Selection of expert panel members
Selection of panelists began with the recruitment of two
co-chairs for each panel, one of whom was selected based
on nationally-recognized leadership in the clinical do-
main and the other based on having expertise in CDS
within the specialty. Co-chairs were selected in con-
sultation with relevant specialty societies (such as the
American College of Cardiology) and with staff of the
AMA-PCPI, which is working with a broad range of
specialties to set quality improvement objectives. After
recruiting the panel co-chairs, we first consulted with
them to refine the panel’s scope, setting bounds that
would enable covering high-priority areas within the
time available for the panel’s work. We then selected
and recruited individual panelists based on their clinical
expertise, community influence (i.e., in professional orga-
nizations for their specialty and serving on advisory
panels related to quality of care, practice improvement,
and/or use of health IT), and the diversity of settings in
which they practice (to reflect both academic and com-
munity practice). For condition-specific panels, members
were also selected to represent a balance of the special-
ties involved in caring for the conditions in question. For
specialty-specific panels we also sought to include a rele-
vant range of clinical sub-domains within the specialty.
The panel size was not fixed across panels. We selected
approximately 14-17 members per panel to ensure that
we would have a minimum of 9 panelists to complete the
Delphi rating process after allowing for attrition.
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the protocol
We selected four panels with different characteristics to
maximize the amount of information learned during the
pilot. To test variations on the definition of a panel’s
area of clinical focus, we selected 1) one medical spe-
cialty (oncology), 2) one surgical specialty (orthopedic
surgery), 3) one non-surgical procedural specialty (inter-
ventional cardiology), and 4) one primary care specialty
(pediatrics). Key factors considered in selecting the
focus, content and membership of the panels were as
follows:
Ensuring diversity of clinical workflows The four
panels were deliberately selected to represent a diverse
set of workflows with known performance gaps poten-
tially amenable to CDS. These workflows included: 1)
Managing transitions between inpatient and ambulatory
care settings (orthopedic surgery, interventional cardi-
ology, oncology); 2) Care coordination with other specia-
lists (oncology, interventional cardiology, pediatrics), 3)
Care coordination during emergencies (interventional
cardiology), 4) Selecting and implementing treatment
protocols when the evidence base may be rapidly evolv-
ing (oncology); 5) Care provided by non-physician staff
with specialized training (orthopedic surgery); 6) Work-
flows specific to different phases of illness (oncology);
and 7) Long-term follow up and management (oncology,
pediatrics) potentially facilitated by the use of registries
(interventional cardiology, oncology).
Variation in the use of EHRs and CDS We also
selected specialties that were known to be relatively
advanced users of CDS (oncology) as well as those that
were not known for having a high level of CDS develop-
ment or EHR adoption (orthopedic surgery).
Additional boundaries on clinical scope within
specialty
Because the project was charged with developing and
pilot testing a priority-setting protocol within a limited
timeframe, we limited the clinical scope of each panel by
selecting important specialty sub-domains, clinical con-
ditions, or both, in consultation with the panel co-chairs.
The considerations for each panel were as follows.
Oncology The oncology panel focused on medical on-
cology in recognition of the fact that medical oncologists
are responsible for the largest share of all health expen-
ditures for oncology. Also, given the large number of dif-
ferent cancers that could be addressed, we limited the
focus to two of the most prevalent cancers, breast and
colorectal cancer. While radiation oncologists and surgi-
cal oncologists have very different workflows that maydefine different CDS opportunities, we included two ra-
diation oncologists and two surgeons on the panel to ad-
dress the fact that medical oncologists commonly
coordinate patient care with these other specialists.
Thus, the oncology panel used a more condition-specific
approach and it included input from multiple related
specialties, but it still focused on care processes deliv-
ered by oncologists, such as the planning and adminis-
tration of chemotherapy.
Orthopedics The scope of the orthopedics panel was
confined to total hip and total knee replacement surgery,
two of the most common procedures within the spe-
cialty. Many workflows and performance gaps associated
with total joint replacement were also thought to be rep-
resentative of those characteristic of other types of
orthopedic surgery. We included a small number of
spine and hand surgeons as well as a number of general
orthopedic surgeons to understand areas where perform-
ance gaps and CDS opportunities might be common
across these other areas.
Pediatrics While our pediatrics panel consisted entirely
of pediatricians, a small number of panelists had expert-
ise in selected pediatric clinical areas, such as allergy
and behavioral health. The scope of the panel was
restricted to pediatric conditions that were mostly trea-
ted in primary care settings.
Interventional cardiology For the interventional cardi-
ology panel, we focused on percutaneous coronary inter-
vention (PCI) both in the management of Acute Coronary
Syndrome (ACS) as well as stable Coronary Artery Dis-
ease (CAD). Primary care-related performance gaps, such
as the management of cholesterol levels, were not
included. However, to make the panel more condition-
specific rather than strictly specialty-focused, we included
internists, interventional and non-interventional cardiolo-
gists, and electrophysiologists who had expertise related
to the role of PCI and its coordination in managing ACS
or stable CAD.
Members for each panel were selected based on the
criteria noted above. We started by recruiting members
who were known contributors to existing AMA-PCPI
performance measurement panels—including those re-
lating to breast cancer, colorectal cancer, and PCI. Many
of the individuals had been nominated by their specialty
organizations for developing performance measures
through the AMA-PCPI. We then added clinical experts
who were identified based on outreach to specialty orga-
nizations, use of key informants, and personal know-
ledge of experts by the project team. Because orthopedic
surgeons were not heavily represented on any existing
AMA-PCPI panels, we requested assistance from the
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and the North American Spine Society (NASS) to iden-
tify suitable experts, and particularly those individuals
who had expertise with EHRs or clinical decision sup-
port. AAOS engaged in an open call to their member-
ship while NASS recommended specific candidates.Results
The protocol was successfully implemented within each of
the four specialty panels, and each produced lists of high
priority targets amenable to CDS (Table 9). Each panel
considered an initial set of 22 to 28 performance gaps, in-
cluding numerous gaps nominated by individual panelists.
Following the first stage of ratings, 6 to 15 gaps were clas-
sified as high priority across the four panels, with some
panels endorsing gaps much more selectively than other
panels. For example, orthopedic surgery and pediatrics
panelists endorsed fewer than 21 percent and 39 percent
of gaps, respectively, as highly important. Notably, less
than half of the 43 clinical performance gaps that were
rated “high priority” were based on quality measures, sug-
gesting that clinical observation is an important source of
data for determining priorities for CDS.
Only the oncology panel found an abundance of highly
effective and workflow-compatible CDS opportunities to
address the high priority performance gaps. Fourteen of
fifteen gaps were determined to be amenable to CDS
compared to only 27, 36, and 50 percent of gaps for
pediatrics, interventional cardiology, and orthopedic sur-
gery, respectively. Nevertheless, all panels achieved con-
sensus on at least 3 high priority targets for CDS. The
complete set of rating results is available elsewhere.
All ratings were completed in a short timeframe with
limited attrition. Preparation for and recruitment of the
four panels was completed in 6 months and the panel
protocol was implemented for all panels in only three
months. Attrition by panelists was low despite a
requirement for panelists to participate in all threeTable 9 Number of CDS targets rated high priority, by
panel
Panel Performance
gaps
considered
“High priority”
performance
gaps
“High priority”
performance
gaps with
effective and
feasible CDS
opportunities
Oncology 22 15 14
Orthopedic
surgery
28 6 3
Pediatrics 28 11 3
Interventional
cardiology
23 11 4teleconferences. Only two to three experts per panel
withdrew during the course of the study. Our staged ap-
proach and use of webmeetings, were designed specific-
ally to minimize participant burden and to enable rapid
completion of the rating tasks and appeared to play a
key role in the success of the pilot.
The need to implement the protocol in a short time-
frame significantly limited the scope of our study. First,
we were unable to conduct an extensive test of alterna-
tive frameworks and protocols for eliciting CDS targets.
For example, we might have explored the use of a proto-
col that elicited very specific decision rules (rather than
the broader construct of “targets”). We also might have
incorporated specific workflows within which CDS
might be optimally deployed in the rating tasks. These
alternative frameworks may be worthy of additional
study. Because of time constraints, we also did not allow
panelists to nominate CDS opportunities beyond those
developed by staff in conjunction with panel co-chairs.
While a more comprehensive elicitation of available
CDS interventions for each target might influence rat-
ings, panelists were directed to rate the overall effective-
ness and compatibility of the set of interventions for
each performance gap as well as any other interventions
that were not presented or discussed.
Rating the effectiveness and compatibility of CDS
interventions appeared to be the most complex task for
panelists. Many existing CDS interventions were
described in the literature with varying levels of detail,
and many CDS interventions rated by panelists were
only concepts and were therefore difficult to fully spe-
cify. Developing standard templates for CDS interven-
tions for use in future implementations of the protocol
would help panelists have a common set of information
on existing tools or tool concepts to facilitate the rating
task. In addition, outreach to the vendor community to
identify existing tools or tools in development might
provide a more comprehensive set of CDS interventions
to inform panelists’ ratings. Each of these preparatory
activities highlights the importance of having an ad-
equate number of skilled staff to conduct literature
reviews and compile preliminary sets of rating items.
The validity of the final set of high priority CDS targets
could depend on the extent to which these initial activ-
ities are effective in identifying a comprehensive set of
performance gaps and CDS interventions.
Conclusion
The extent to which CMS’s EHR Incentive Programs will
stimulate HIT-enabled quality improvement will depend
to a large extent on the way in which meaningful use
objectives are specified. We developed a conceptual
framework and protocol for eliciting high priority CDS
targets that are clinically important and that are
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from specialists and reflect consensus recommendations
following rating exercises and group discussions. While
the targets are specific, they allow for a broad range of
CDS interventions that can be used to address each per-
formance gap. Such an approach recognizes specialists’
own experience and preferences for CDS while main-
taining strong incentives for vendor innovation. CDS
targets could be used to specify meaningful use objec-
tives for the CMS EHR Incentive Programs or could play
a role in other pay-for-performance programs.
Endnotes
aThis definition is a hybrid of the CDS definitions from
the Health Information Management Systems Society
(HIMSS) [39] and from CMS [36].
Authors’ contributions
DB, JT, CD, and ES developed the conceptual framework and protocol, JT
and DB drafted the manuscript. All authors read and approved the final
manuscript.
Acknowledgments
This study was funded by the U.S. Office of the National Coordinator (ONC)
for Health Information Technology, through contract HHSP23320095649WC,
task order HHSP23337009T. The authors thank Liisa Hiatt for expert
management of the project and Jonathan Teich, MD, Ph.D. for his
contributions to our thinking about this project and for his critical review of
the manuscript. The funder conceived the study, and provided feedback on
the development of the protocol, but did not contribute to the drafting of
the manuscript.
Author details
1RAND Corporation, 1200 South Hayes Street, Arlington, VA 22202, USA.
2Rand Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA 90407,
USA. 3Rand Corporation, 20 Park Plaza, 9th Floor, Suite 920, Boston, MA
02116, USA. 4Rand Corporation, 1776 Main Street, P.O. Box 2138, Santa
Monica, CA 90407, USA.
Received: 25 January 2012 Accepted: 21 August 2012
Published: 3 September 2012
References
1. Institute of Medicine (U.S.). Committee on Quality of Health Care in
America: Crossing the quality chasm: a new health system for the 21st century.
Washington: National Academy Press; 2001.
2. Gorry GA, Barnett GO: Sequential diagnosis by computer. Jama 1968,
205(12):849–854.
3. Shortliffe EH, Davis R, Axline SG, Buchanan BG, Green CC, Cohen SN:
Computer-based consultations in clinical therapeutics: explanation and
rule acquisition capabilities of the MYCIN system. Comput Biomed Res
1975, 8(4):303–320.
4. Berner ES, Maisiak RS, Cobbs CG, Taunton OD: Effects of a decision support
system on physicians' diagnostic performance. J Am Med Inform Assoc
1999, 6(5):420–427.
5. Friedman CP, Elstein AS, Wolf FM, Murphy GC, Franz TM, Heckerling PS, Fine
PL, Miller TM, Abraham V: Enhancement of clinicians' diagnostic
reasoning by computer-based consultation: a multisite study of 2
systems. JAMA 1999, 282(19):1851–1856.
6. Samore MH, Bateman K, Alder SC, Hannah E, Donnelly S, Stoddard GJ,
Haddadin B, Rubin MA, Williamson J, Stults B, et al: Clinical decision
support and appropriateness of antimicrobial prescribing: a randomized
trial. JAMA 2005, 294(18):2305–2314.
7. Graber ML, Mathew A: Performance of a web-based clinical diagnosis
support system for internists. J Gen Intern Med 2008, 23(Suppl 1):37–40.8. Elkin PL, Liebow M, Bauer BA, Chaliki S, Wahner-Roedler D, Bundrick J, Lee
M, Brown SH, Froehling D, Bailey K, et al: The introduction of a diagnostic
decision support system (DXplain) into the workflow of a teaching
hospital service can decrease the cost of service for diagnostically
challenging Diagnostic Related Groups (DRGs). Int J Med Inform 2010,
79(11):772–777.
9. Institute of Medicine (U.S.). Committee on Crossing the Quality Chasm:
Adaptation to Mental Health and Addictive Disorders: Improving the quality
of health care for mental and substance-use conditions. Washington: National
Academies Press; 2006.
10. Hunt DL, Haynes RB, Hanna SE, Smith K: Effects of computer-based clinical
decision support systems on physician performance and patient
outcomes: a systematic review. Jama 1998, 280(15):1339–1346.
11. Bates DW, Pappius E, Kuperman GJ, Sittig D, Burstin H, Fairchild D, Brennan
TA, Teich JM: Using information systems to measure and improve quality.
Int J Med Inform 1999, 53(2–3):115–124.
12. Kuperman GJ, Teich JM, Gandhi TK, Bates DW: Patient safety and
computerized medication ordering at Brigham and Women's Hospital.
Jt Comm J Qual Improv 2001, 27(10):509–521.
13. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ,
Beyene J, Sam J, Haynes RB: Effects of computerized clinical decision
support systems on practitioner performance and patient outcomes: a
systematic review. Jama 2005, 293(10):1223–1238.
14. Kawamoto K, Houlihan CA, Balas EA, Lobach DF: Improving clinical practice
using clinical decision support systems: a systematic review of trials to
identify features critical to success. BMJ 2005, 330(7494):765.
15. Schedlbauer A, Prasad V, Mulvaney C, Phansalkar S, Stanton W, Bates DW,
Avery AJ: What evidence supports the use of computerized alerts and
prompts to improve clinicians' prescribing behavior? J Am Med Inform
Assoc 2009, 16(4):531–538.
16. Amarasingham R, Plantinga L, Diener-West M, Gaskin DJ, Powe NR: Clinical
information technologies and inpatient outcomes: a multiple hospital
study. Arch Intern Med 2009, 169(2):108–114.
17. Jaspers MW, Smeulers M, Vermeulen H, Peute LW: Effects of clinical
decision-support systems on practitioner performance and patient
outcomes: a synthesis of high-quality systematic review findings. J Am
Med Inform Assoc 2011, 18(3):327–334.
18. McDonald CJ, Overhage JM: Guidelines you can follow and can trust. An
ideal and an example. Jama 1994, 271(11):872–873.
19. Overhage JM, Tierney WM, Zhou XH, McDonald CJ: A randomized trial of
"corollary orders" to prevent errors of omission. J Am Med Inform Assoc
1997, 4(5):364–375.
20. Maviglia SM, Zielstorff RD, Paterno M, Teich JM, Bates DW, Kuperman GJ:
Automating complex guidelines for chronic disease: lessons learned.
J Am Med Inform Assoc 2003, 10(2):154–165.
21. Sintchenko V, Coiera E, Iredell JR, Gilbert GL: Comparative impact of
guidelines, clinical data, and decision support on prescribing decisions:
an interactive web experiment with simulated cases. J Am Med Inform
Assoc 2004, 11(1):71–77.
22. Eslami S, Abu-Hanna A, de Keizer NF: Evaluation of outpatient
computerized physician medication order entry systems: a systematic
review. J Am Med Inform Assoc 2007, 14(4):400–406.
23. Pearson SA, Moxey A, Robertson J, Hains I, Williamson M, Reeve J, Newby D:
Do computerised clinical decision support systems for prescribing
change practice? A systematic review of the literature (1990-2007). BMC
Health Serv Res 2009, 9:154.
24. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J:
The effects of on-screen, point of care computer reminders on processes
and outcomes of care. Cochrane Database Syst Rev 2009, (3):CD001096.
25. Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma’Luf N, Boyle D, Leape
L: The impact of computerized physician order entry on medication
error prevention. J Am Med Inform Assoc 1999, 6(4):313–321.
26. Teich JM, Merchia PR, Schmiz JL, Kuperman GJ, Spurr CD, Bates DW: Effects
of computerized physician order entry on prescribing practices. Arch
Intern Med 2000, 160(18):2741–2747.
27. Bates DW, Cohen M, Leape LL, Overhage JM, Shabot MM, Sheridan T:
Reducing the frequency of errors in medicine using information
technology. J Am Med Inform Assoc 2001, 8(4):299–308.
28. Kaushal R, Shojania KG, Bates DW: Effects of computerized physician order
entry and clinical decision support systems on medication safety: a
systematic review. Arch Intern Med 2003, 163(12):1409–1416.
Timbie et al. BMC Medical Informatics and Decision Making 2012, 12:93 Page 12 of 12
http://www.biomedcentral.com/1472-6947/12/9329. Kuperman GJ, Bobb A, Payne TH, Avery AJ, Gandhi TK, Burns G, Classen DC,
Bates DW: Medication-related clinical decision support in computerized
provider order entry systems: a review. J Am Med Inform Assoc 2007,
14(1):29–40.
30. Kaushal R, Kern LM, Barron Y, Quaresimo J, Abramson EL: Electronic
prescribing improves medication safety in community-based office
practices. J Gen Intern Med 2010, 25(6):530–536.
31. Saleem JJ, Patterson ES, Militello L, Render ML, Orshansky G, Asch SM:
Exploring barriers and facilitators to the use of computerized clinical
reminders. J Am Med Inform Assoc 2005, 12(4):438–447.
32. Miller RH, Sim I: Physicians' use of electronic medical records: barriers
and solutions. Health Aff (Millwood) 2004, 23(2):116–126.
33. Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson SA:
Computerized clinical decision support for prescribing: provision does
not guarantee uptake. J Am Med Inform Assoc 2010, 17(1):25–33.
34. Sittig DF, Wright A, Osheroff JA, Middleton B, Teich JM, Ash JS, Campbell E,
Bates DW: Grand challenges in clinical decision support. J Biomed Inform
2008, 41(2):387–392.
35. Blumenthal D, Tavenner M: The "meaningful use" regulation for electronic
health records. N Engl J Med 2010, 363(6):501–504.
36. Centers for Medicare and Medicaid Services: Medicare and Medicaid
Programs; Electronic Health Record Incentive Program. 2010,
75:44314–44588. FR 44314: Federal Register.
37. Centers Medicare and Medicaid Services: Medicare and Medicaid
Programs Electronic Health Record Incentive Program–Stage 2. 2012,
77:13698–13829. FR 45: Federal Register.
38. National Priorities Partnership [website] http://www.nationalprioritiespartnership.org/.
39. Osheroff JA, Pifer EA, Teich JM, Sittig DF, Jenders RA: Improving Outcomes
with Clinical Decision Support: An Implementer's Guide. Chicago: HIMSS; 2005.
40. Schnipper JL, Linder JA, Palchuk MB, Einbinder JS, Li Q, Postilnik A,
Middleton B: "Smart Forms" in an Electronic Medical Record:
documentation-based clinical decision support to improve disease
management. J Am Med Inform Assoc 2008, 15(4):513–523.
41. Marâia D, Bernstein S, Burnand B, Fitch K, Kahan JP, LaCalle JR, Lazaro P, Loo
M, McDonnell J, Vader J: The RAND/UCLA appropriateness method user's
manual. Santa Monica, CA: RAND Corporation; 2001.
doi:10.1186/1472-6947-12-93
Cite this article as: Timbie et al.: A conceptual framework and protocol
for defining clinical decision support objectives applicable to medical
specialties. BMC Medical Informatics and Decision Making 2012 12:93.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
